CD8A and cancer: Notably, in the high‐expression group, cancer cells enhanced interactions with M1 macrophages, CD8+ effector T cells, and Bregs through HEBP1−EGFR, YARS−EGFR, and ICAM1−EGFR pathways, respectively.